Template:Erysipelas antibiotics: Difference between revisions

Revision as of 01:00, 20 March 2026

Coverage for S. pyogenes

Penicillin G 300K U/d IM for <30 kg, 600K to 1 million U/d IM for >30 kg (first line therapy^[1]) OR
Clindamycin 450mg (5mg/kg) PO q8hrs x 10 days (if PCN allergic) OR
Cephalexin 500mg (6.25mg/kg) PO q6hrs x 10 days OR
Ceftriaxone 1g (50mg/kg) IV once daily x 10 days OR
Levofloxacin 500mg PO/IV daily x 10 days OR
Amoxicillin/Clavulanate 500mg PO BID x 10 days (generally reserved for failure of first line therapy)

Bullous Erysipela or MRSA suspected: trimethoprim-sulfamethoxazole, clindamycin, doxycycline, or minocycline

↑ Linke M, Booken N. Risk factors associated with a reduced response in the treatment of erysipelas. J Dtsch Dermatol Ges. 2015 Mar;13(3):217-25.

[Linke-1] Linke M, Booken N. Risk factors associated with a reduced response in the treatment of erysipelas. J Dtsch Dermatol Ges. 2015 Mar;13(3):217-25.

[1]

@@ Line 1: / Line 1: @@
 ''Coverage for [[S. pyogenes]]''
-*[[Penicillin G]] 300K U/d IM for <30 kg, 600K to 1 million U/d IM for >30 kg (first line therapy<ref name="Linke">Linke M, Booken N. Risk factors associated with a reduced response in the treatment of erysipelas. J Dtsch Dermatol Ges. 2015 Mar;13(3):217-25.</ref>) '''OR'''
+*{{AntibioticDose|disease=Erysipelas|drug=Penicillin G|dose=300K U/d IM for <30 kg, 600K to 1 million U/d IM for >30 kg|context=First Line}} (first line therapy<ref name="Linke">Linke M, Booken N. Risk factors associated with a reduced response in the treatment of erysipelas. J Dtsch Dermatol Ges. 2015 Mar;13(3):217-25.</ref>) '''OR'''
-*[[Clindamycin]] 450mg (5mg/kg) PO q8hrs x 10 days (if PCN allergic) '''OR'''
+*{{AntibioticDose|disease=Erysipelas|drug=Clindamycin|dose=450mg (5mg/kg) PO q8hrs x 10 days|context=PCN Allergic}} (if PCN allergic) '''OR'''
-*[[Cephalexin]] 500mg (6.25mg/kg) PO q6hrs x 10 days '''OR'''
+*{{AntibioticDose|disease=Erysipelas|drug=Cephalexin|dose=500mg (6.25mg/kg) PO q6hrs x 10 days|context=Alternative}} '''OR'''
-*[[Ceftriaxone]] 1g (50mg/kg) IV once daily x 10 days '''OR'''
+*{{AntibioticDose|disease=Erysipelas|drug=Ceftriaxone|dose=1g (50mg/kg) IV once daily x 10 days|context=Inpatient}} '''OR'''
-*[[Levofloxacin]] 500mg PO/IV daily x 10 days '''OR'''
+*{{AntibioticDose|disease=Erysipelas|drug=Levofloxacin|dose=500mg PO/IV daily x 10 days|context=Alternative}} '''OR'''
-*[[Augmentin]] 500mg PO BID x 10 days (generally reserved for failure of first line therapy)
+*{{AntibioticDose|disease=Erysipelas|drug=Amoxicillin/Clavulanate|dose=500mg PO BID x 10 days|context=Treatment Failure}} (generally reserved for failure of first line therapy)
 Bullous Erysipela or [[MRSA]] suspected: [[trimethoprim-sulfamethoxazole]], [[clindamycin]], [[doxycycline]], or [[minocycline]]